tirzepatide weight loss clinical trial New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss What Is Tirzepatide Used for?
Description
Firstly, the utilization of the FAERS and JADER as spontaneous reporting systems may engender incomplete data, potentially predisposing results to biases
Regular check-ins with your healthcare provider are key to having a successful experience
Expect a dose adjustment period
Recording injection dates, doses, any side effects, and progress metrics creates valuable data for refining approaches
At NDA Medical Spa, we believe in science-backed solutions that help you achieve optimal wellness and confidence
